Skip to main content
KD logo

KD · Kyndryl Holdings, Inc.

Track KD — free
$15.33 -0.30 (-1.92%) At close · Nov 19
Market Cap
$3.34B
Shares
217.82M
Volume · Nov 19 2.9M Avg daily vol (3M) 4.05M

Price & Indicators

 

Key stats

Close
$15.33
Open
$15.54
Day range
$15.15–15.80
52-week closing range
$10.59–27.50
Average volume, 30 days
4.1M
Short interest
28.4M · 13.0% of shares · 7.4 days
Short volume, last session
59%
Last earnings
Nov 4, 2026
Latest filing
10-Q · Nov 4
Price history
Oct 2021 to Nov 2026

Up next

Feb 8, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 4
Earnings call
Revenue falls 1.9% as fiscal 2027 outlook is reaffirmed

Kindrel reported Q2 revenue of $3.65 billion, down 1.9% year-over-year, while reaffirming fiscal 2027 adjusted pre-tax income of $600 million to $700 million and free cash flow of $400 million to $500 million.

4 source passages
In Q2, we generated $3.65 billion of revenue. Down 1.9% year-over-year, as reported, and down 80 points in constant currency. Turning to our outlook for fiscal 2027, we continue to expect adjusted pre-tax income to be in the range of $600 million to $700 million. For the full year, we continue to expect free cash flow in the range of $400 million to $500 million. Kindrel Consult's growth reflects demand for modernization, including the integration of agentic AI across infrastructure, applications, and workflows with cybersecurity, governance, Open the document at this passage
Nov 4
Quarterly report 10-Q FY2027 Q2, ended Sep 30
Revenue Declines and Net Income Falls

Kyndryl reported six-month revenue of $7.3 billion, down 2.6 percent, and net income of $4 million compared with $124 million; adjusted EBITDA was $1,211 million compared with $1,288 million.

Revenue $3.65B ▼ 1.9% Net income $59M ▼ 13.2% Diluted EPS $0.27 ▼ 6.9%
Read from the MD&A section
4 source passages
Kyndryl is a leading provider of mission-critical enterprise technology services, offering advisory, implementation and managed service capabilities to thousands of customers in more than 60 countries. For the six months ended September 30, 2026, we reported $7.3 billion in revenue, a decrease of 2.6 percent, and a decrease of 2.1 percent in constant currency, compared to the prior-year period. Net income was $4 million in the six months ended September 30, 2026 compared to net income of $124 million in the six months ended September 30, 2025, driven by a $146 million increase in workforce rebalancing charges and a $38 million increase in impairment expense driven by the sale of a facility in the United States, partially offset by a $40 million gain from the sale of a wholly-owned digital solutions subsidiary in the Principal Markets segment (classified as a transaction-related benefit) in the current period. Adjusted EBITDA | | | $ | 699 | | | | $ | 641 | | | $ | 1,211 | | | $ | 1,288 Open the document at this passage
Nov 4
Current report 8-K
Fiscal 2027 outlook reaffirmed despite revenue decline

Kyndryl reported second-quarter revenues of $3.7 billion, down 1.9% year-over-year, and net income of $59 million. It reaffirmed fiscal 2027 outlook, including adjusted pretax income of $600 to $700 million and free cash flow of $400 to $500 million.

Financial results
5 source passages
For the second quarter, Kyndryl reported revenues of $3.7 billion, down 1.9% year-over-year on a reported basis and down 0.8% year-over-year in constant currency. Revenues for the quarter ended September 30, 2026 total $3.7 billion, pretax income is $112 million, and net income is $59 million Company reaffirms fiscal 2027 outlook Adjusted pretax income of $600 to $700 million Free cash flow of $400 to $500 million Open the document at this passage
Sep 28
Current report 8-K Events of Sep 24
Other events

Kyndryl Holdings, Inc. issued $600,000,000 of 7.800% Senior Notes due September 28, 2029 and $400,000,000 of 7.875% Senior Notes due January 15, 2032. Proceeds will repay $700 million of 2.05% notes due October 2026 and the revolving credit agreement.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$14.90B
Trailing 12 months
Net income (TTM)
$78.00M
Trailing 12 months
Revenue growth YoY
-1.9%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
43.8
Trailing earnings · reciprocal yield 2.3%
FCF yield
2.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$3.21B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-7.1%
Year over year · fewer shares
Price change (1Y)
-35.0%
Trailing year
Short interest
13.0%
Latest settlement · 7.4 days to cover
View all 125 metrics

AI Brief

Q2 FY27 earnings call · Nov 4, 2026
Q2 FY27

TL;DR. Signings, Kyndryl Consult, hyperscaler-related revenue and U.S. revenue grew, while adjusted earnings and margins improved; Kyndryl also reaffirmed fiscal 2027 free-cash-flow guidance, maintained its fiscal 2028 objectives and expanded through Healthcare IT Leaders. Q2 revenue, GAAP net income and free cash flow declined, interest and amortization rose, and fiscal 2027 constant-currency revenue guidance remained flat to down 2%.

Bullish
  • + Hyperscaler-related revenue grew 27.2% in Q2 and 38.5% over the trailing twelve months.
  • + Adjusted earnings and margins improved year over year in Q2.
Bearish
  • − GAAP net income declined to $59 million from $68 million, and diluted EPS fell to $0.27 from $0.29.
  • − Interest expense increased to $37 million from $20 million, and full-year interest expense is now expected to be approximately $160 million.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +18%
above
Price vs 50-day avg +12%
above
RSI (14) 52
neutral
MACD trend Negative
52-week position 28%
mid-range
Momentum
relative strength
Strong
1-month return +1%
trailing
6-month return +19%
trailing
YTD return −42%
this year
Relative strength +25%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $14 › 200d $13 — 50d above 200d
Institutional flow Distributing
-6% holders QoQ · +61 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
13.05% of shares out · ▼ -14.1% MoM · 7.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
652 holders — mid 3-yr range
Squeeze score 75
high risk · 0–100
Fundamentals
Fair
Revenue growth +0%
Y/Y
EPS growth −19%
Y/Y
Free cash flow $196.0M
Valuation P/E 43.8
rich
Buyback $205.0M
remaining
Balance sheet $2.3B
net debt
Quant / Vol
risk profile
Very High
Volatility 81%
annualized · 1-yr
Max drawdown −61%
past year
ATR 5.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Nov 4, 2026
Adjusted pretax income · fiscal 2027 (April 2026 to March 2027) Non-GAAP $600M – $700M
Free cash flow · fiscal 2027 (April 2026 to March 2027) Non-GAAP $400M – $500M
Previous outlook earlier release · from the Earnings Call filed Aug 5, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted pre-tax income · fiscal year 2027 $600M – $700M
Adjusted pre-tax income · fiscal year 2028 at least $1.2B
Annualized savings from workforce rebalancing actions · fiscal 2028 $400M – $500M
Free cash flow · full year fiscal 2027 $400M – $500M
Prior guidance period ended · from the 8-K filed Feb 9, 2026
Adjusted pretax income · fiscal year 2026 $575M – $600M
Adjusted EBITDA margin · fiscal year 2026 17.5%
Free cash flow · fiscal year 2026 $325M – $375M
Guided vs delivered · last 1 settled
Revenue fiscal year beginning April 1, 2022 and ending March 31, 2023
guided $16.3B – $16.5B
$17.03B Beat +3.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+18% Bullish
Price vs 50-day avg
+12% Bullish
RSI (14)
52 Neutral
MACD trend
Negative Bearish
52-week position
28% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $14 › 200d $13 — 50d above 200d
Institutional flow Distributing
-6% holders QoQ · +61 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
13.05% of shares out · ▼ -14.1% MoM · 7.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
652 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $11 Now $15 · 28% Range high $28
vs 200-day avg +18% vs 50-day avg +12%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $512M Q1 FY2027 —
GAAP → non-GAAP reconciliation
Adjusted pretax income (loss) (non-GAAP) -37M (non-GAAP)
+34M Interest expense
+183M Depreciation of property, equipment and capitalized software
+331M Amortization of transition costs and prepaid software
= Adjusted EBITDA 512M
Adjusted EBITDA margin non-GAAP 14.2% Three Months Ended June 30, 2026 —
Free cash flow non-GAAP $401M Q1 FY2027 —
Segment adjusted EBITDA - Japan non-GAAP $109M Three Months Ended June 30, 2026 —
Segment adjusted EBITDA - Principal Markets non-GAAP $151M Three Months Ended June 30, 2026 —
Segment adjusted EBITDA - Strategic Markets non-GAAP $62M Three Months Ended June 30, 2026 —
Segment adjusted EBITDA - United States non-GAAP $220M Three Months Ended June 30, 2026 —
Signings $3.9B Q1 FY2027 (first quarter) —
Total Segments adjusted EBITDA non-GAAP $542M Three Months Ended June 30, 2026 filing —
Total signings $3.9B Three Months Ended June 30, 2026 filing —
Adjusted EBITDA (Principal Markets) non-GAAP $834M year ended March 31, 2026 filing —
Adjusted EBITDA (Strategic Markets) non-GAAP $622M year ended March 31, 2026 filing —
Adjusted EBITDA loss (Corporate and other) non-GAAP $105M year ended March 31, 2026 filing —
five largest customers share of revenue 10% fiscal year 2026 filing —
Revenue growth in constant currency non-GAAP -3% year ended March 31, 2026 filing —
Segment adjusted EBITDA non-GAAP $2.78B Year Ended March 31, 2026 filing —
share of revenue from financial services industry 45% fiscal year ended March 31, 2026 filing —
Shares repurchased under Share Repurchase Program 11.6M year ended March 31, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Information Technology Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
KD
Kyndryl Holdings, Inc.
this stock
$3.34B -42.3% +0.2% 43.8 13.0%
IBM
International Business Machines Corp
$211.59B -24.4% +7.6% 19.1 1.9%
ACN
Accenture plc
$146.24B -18.5% +6.5% 16.1 3.2%
INFY
Infosys Ltd
$47.19B -34.6% — — 2.1%
CTSH
Cognizant Technology Solutions Corp
$25.17B -32.2% +7.0% 10.3 5.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
652
% held
88.9%
Net QoQ
+1.6M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
339
View
Short & Settlement
Short Interest Falling
Shares short
28.4M
Days to cover
7.4d
Change
-4.6M sh
View
Short Volume
Short vol %
59%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
2.2K
Value
$31.7K
As of
Oct 28, 2026
View
Off-Exchange
Off-exchange %
37.1%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
James French Hill
Amount
$1.0K–$15.0K
Traded
Dec 31, 2025
View
Financials
Financials
Revenue (FY)
$15.1B
EPS diluted
$0.85
View
Buybacks
Authorized
$400.0M
Remaining
$205.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 4, 2026
This year
23

Kyndryl reported second-quarter revenues of $3.7 billion, down 1.9% year-over-year, and net income of $59 million. It reaffirmed fiscal 2027 outlook, including adjusted pretax income of $600 to $700 million and free cash flow of $400 to $500 million.

View
Proposed Sales
Value
$509.3K
Shares
40.1K
Filed
Aug 12, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 4, 2026
View
Investor Relations
Latest news
Kyndryl Unveils New Sovereignty A…
Published
Nov 12, 2026
View

Performance

5D 20D 120D MTD YTD
KD -10.1% +0.9% +18.9% +10.9% -42.3%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -4.7% +7.2% +24.6% +16.1% -47.3%

Capital returns

Buyback program · as of Sep 30, 2026
Authorized
$400.00M
Spent (derived)
$195.00M
Remaining
$205.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1867072 CUSIP 50155Q100 13F (30d) 653 filings 566 filers Visit website Investor relations